Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway

BACKGROUND: KCNJ2/Kir2.1, a member of the classical inwardly rectifying potassium channel family, is commonly expressed in a wide range of tissues and cell types. Previous studies indicated that Kir2.1 may be associated with SCLC multidrug resistance (MDR). However, whether Kir2.1 can regulate MDR a...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Huanxin, Huang, Jie, Peng, Juan, Wu, Xiaoxia, Zhang, Yan, Zhu, Weiliang, Guo, Linlang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373128/
https://www.ncbi.nlm.nih.gov/pubmed/25880778
http://dx.doi.org/10.1186/s12943-015-0298-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373128/
https://www.ncbi.nlm.nih.gov/pubmed/25880778
http://dx.doi.org/10.1186/s12943-015-0298-0

Ejemplares similares